Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid

Figure 2

Cell line comparison of viability reduction by thio-ccPA 18:1. (A) B16F10, A375 and MeWo melanoma cells were treated with increasing concentrations (0-100 μM) of thio-ccPA 18:1 for 48 h and examined for viability. *p < 0.05 and ***p < 0.001 vs. control by Bonferroni's t-test and analysis of variance. (B) A549, MDA-MB-231 and MeWo melanoma cells were treated with either 40 μM or 20 μM of thio-ccPA 18:1 and examined for viability. Results show the percent of viability compared to vehicle (dH2O). **p < 0.01 vs. vehicle by Bonferroni's t-test and analysis of variance.

Back to article page